PMID: 7526794Jul 1, 1994Paper

Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy

Antiviral Research
G Antonelli

Abstract

Since the 1970's, people started to use interferon as a therapeutic agent against infectious and neoplastic diseases. Since the beginning of its therapeutical use, it was demonstrated that some patients produce, when treated with interferon, antibodies able to neutralize its biological activity. This paper will review and discuss what it is currently known about the technical, biological, and clinical aspects of these antibodies.

References

May 1, 1990·Immunology Today·K BendtzenE Hippe
Dec 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokE K Leung
Sep 2, 1989·Lancet·J E GaltonA B Nethersell
May 4, 1988·Journal of the National Cancer Institute·H M GolombE Bonnem
Nov 28, 1981·Lancet·K E MogensenB Varet
Dec 1, 1983·Diabetologia·S E FinebergS Hufferd

❮ Previous
Next ❯

Citations

Sep 1, 1995·Medicinal Research Reviews·G C ViscomiS Silvestri
Dec 20, 1995·Toxicology·T Vial, J Descotes
Aug 24, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M A TakacsS J Swanson
Dec 1, 2001·Expert Opinion on Biological Therapy·H C ChiouC P Lollo
Jul 22, 2006·Expert Opinion on Biological Therapy·Francesca BagnatoGuido Antonelli
Feb 10, 2009·Journal of Pharmaceutical Sciences·Kaya BorkWenke Weidemann
Jan 30, 1999·Ocular Immunology and Inflammation·A A OkadaJ Mizuguchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.